Skip to main content
. 2024 Nov 22;17(Suppl 2):ii9–ii18. doi: 10.1093/ckj/sfae277

Figure 1:

Figure 1:

Results of a survey of European centres (n = 288) showing the proportion of prevalent patients treated with PD by region across Europe [56, 57].